Brainstorm Cell Therapeutics

Price & Volume

Stats

Open	$1.31
Previous Close	$1.35
Day Range	$1.18-$1.31
52W Range	$1.05-$11.25
Market Cap	$7.9M
Shares Short	110,846

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$3.33

News

Yahoo Finance • last year

DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • last year

BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm

Yahoo Finance • last year

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline

Yahoo Finance • last year

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)

About

CEO	Mr. Chaim Lebovits
CFO	Ms. Alla Patlis CPA, M.B.A.
Address	1325 Avenue of Americas, New York, NY, United States, 10019
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	29